Labaz en es it fr

Labaz Brand names, Labaz Analogs

Labaz Brand Names Mixture

  • No information avaliable

Labaz Chemical_Formula


Labaz RX_link

Labaz fda sheet

Labaz FDA

Labaz msds (material safety sheet)

Labaz MSDS

Labaz Synthesis Reference

No information avaliable

Labaz Molecular Weight

645.312 g/mol

Labaz Melting Point

No information avaliable

Labaz H2O Solubility


Labaz State


Labaz LogP


Labaz Dosage Forms

Liquid; Solution; Tablet (200 mg and 400 mg)

Labaz Indication

Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.

Labaz Pharmacology

Amiodarone belongs to a class of drugs called Vaughan-Williams Class III antiarrhythmic agents. It is used in the treatment of a wide range of cardiac tachyarhthmias, including both ventricular and supraventricular (atrial) arrhythmias. After intravenous administration in man, amiodarone relaxes vascular smooth muscle, reduces peripheral vascular resistance (afterload), and slightly increases cardiac index. Amiodarone prolongs phase 3 of the cardiac action potential. It has numerous other effects however, including actions that are similar to those of antiarrhythmic classes Ia, II, and IV. Amiodarone shows beta blocker-like and calcium channel blocker-like actions on the SA and AV nodes, increases the refractory period via sodium- and potassium-channel effects, and slows intra-cardiac conduction of the cardiac action potential, via sodium-channel effects.

Labaz Absorption

Slow and variable (about 20 to 55% of an oral dose is absorbed).

Labaz side effects and Toxicity

Intravenous, mouse: LD50 = 178 mg/kg. Some side effects have a significant mortality rate: specifically, hepatitis, exacerbation of asthma and congestive failure, and pneumonitis.

Labaz Patient Information

No information avaliable

Labaz Organisms Affected

Humans and other mammals